Home › Funds › Stonepine Capital Management, LLC › AYTU

Stonepine Capital Management, LLC position in AYTU

AYTU BIOPHARMA INC · Health Care

Stonepine Capital Management, LLC reported holding 964,900 shares of AYTU (AYTU BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 1.59% of its reported portfolio and ranking #16 among its reported holdings. Stonepine Capital Management, LLC has disclosed AYTU holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)964.90K sh
Reported value held$2.06M
Portfolio Weight1.59%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's AYTU position evolved

Stonepine Capital Management, LLC first disclosed a stake in AYTU in Q3 2023 at 472,369 shares (US$1.3M). The position peaked in Q1 2026 at 792,289 shares, worth US$2.2M. Across 13 filings, Stonepine Capital Management, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 964,900 shares valued at US$2.1M — an increase of 51,979 shares quarter over quarter.. Notable position changes include a 75% increase in Q2 2025 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 472.37K $1.28M New
Q4 2023 472.47K $1.34M Hold
Q1 2024 472.47K $1.44M Hold
Q2 2024 472.47K $1.38M Hold
Q3 2024 500.96K $1.18M Add
Q4 2024 407.55K $692.83K Reduce
Q1 2025 463.72K $795.00K Add
Q2 2025 812.68K $1.77M Add
Q3 2025 891.86K $1.68M Add
Q4 2025 813.70K $2.12M Reduce
Q1 2026 792.29K $2.16M Reduce
Q2 2026 912.92K $1.96M Add
Q3 2026 964.90K $2.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AYTU and 13F data

AYTU (AYTU BIOPHARMA INC) is a Health Care company. 28 other funds we track also report a position in AYTU — the largest reported positions include CROWN ADVISORS MANAGEMENT, INC. (US$428K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AYTU

All AYTU fund holders →

FAQ

How long has Stonepine Capital Management, LLC held AYTU?

Stonepine Capital Management, LLC has disclosed AYTU holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Stonepine Capital Management, LLC's current position in AYTU?

As of Q3 2026, Stonepine Capital Management, LLC holds 964.90K shares of AYTU (AYTU BIOPHARMA INC), valued at $2.06M, representing 1.59% of its reported portfolio and ranking #16.

Has Stonepine Capital Management, LLC been buying or selling AYTU?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in AYTU. The position peaked in Q1 2026 at 792.29K shares.

Which other funds hold AYTU?

Other major institutional holders of AYTU include CROWN ADVISORS MANAGEMENT, INC., among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.